NTAGI panel reviews data for Corbevax as booster for adults who got Covishield, Covaxin shots | India News Read more
Centre reduces gap between 2nd & booster doses of Covid vaccine to 6 months from 9 | India News Read more
Allowing Corbevax as booster for those vaccinated with Coivishield, Covaxin likely to be considered by NTAGI | India News Read more
covaxin: NTAGI to review Covaxin, Corbevax data for 6-12 years Thursday, discuss reducing booster dose gap Read more
lancet: AstraZeneca’s Covid-19 vaccine well tolerated and immunogenic in kids aged 6-17 years: Lancet study Read more